Search results
...for Treatment of Adenoid Cystic Carcinoma (ACC) and Acute Myeloid Leukemia/Myelodysplastic...
CBS 47 Fresno· 2 days agoAdditionally, the company also announced that REM-422 has received Orphan Drug Designation from the FDA for the treatment of ACC and AML...
Testing for residual cancer cells before blood cell transplant therapy is important and practical,...
Medical Xpress· 2 days ago"The good news is this testing is doable," said Christopher Hourigan, a Virginia Tech professor of...
Moleculin Announces Formation of Scientific Advisory Board to Support Development of Annamycin
KTLA-TV Los Angeles· 3 days agoMartin Tallman. Dr. Tallman is an internationally renowned clinical investigator whose discoveries have fueled the progress of leukemia-targeting therapies, most recently ...
More bones found in Mass. creek where skull was discovered
The Republican· 1 day agoAdditional human bones were found in Easton on Thursday as officials continued to search the area...
MorphoSys Says Novartis Deal Progressing Steadily Despite Safety Concerns Over Bone Marrow Cancer...
Benzinga· 4 days agoMorphoSys AG MOR is reportedly facing a burgeoning safety concern surrounding pelabresib, an...
Grandmother, granddaughter fight cancer together
The Port Lavaca Wave· 2 days agoWhen faced with cancer at the same time, a grandmother and her grandchild are strengthening their bond as they fight together. Calhoun High School...
Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM) Short Interest Update
ETF DAILY NEWS· 3 days agoActinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM – Get Free Report) saw a large drop in short interest in the month of April. As of April 15th, there was short interest totalling 1,980,000 ...
Myelofibrosis: A Rare Malignancy Attracting More and More Attention
MedPage Today· 3 days agoMyelofibrosis remains a rare disease, even though recent attention to the condition might suggest...
I-95 in Connecticut will close for days after fiery crash damages bridge, governor says
The Republican· 1 day agoThe major traffic artery linking New England with New York will be closed in Connecticut for days...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 1 day agoPomerantz LLP announces that a class action lawsuit has been filed against bluebird bio, Inc. (“bluebird” or the “Company”) (NASDAQ: BLUE). Such investors are advised to contact Danielle Peyton ...